In contrast, TS induced CXCR3 expression of CD4+Tregs at peripheral sites suppress the immune response and systemic inflammatory cytokines, thus reducing inflammation and leading to effective suppression of both colitis and associated colorectal cancer. Here, CXCR3 is linked to colorectal cancer.